FDCC
INSP icon

Foster Dykema Cabot & Co’s Inspire Medical Systems INSP Stock Holding History

Foster Dykema Cabot & Co’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-31
Closed -$10K – 358
2023
Q2 		$10K Buy
+31
New +$8.86K ﹤0.01% 240

Other funds holding INSP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Foster Dykema Cabot & Co's INSP Position: Q3 2023 in Review

Foster Dykema Cabot & Co sold out of Inspire Medical Systems (INSP) in Q3 2023, closing a stake of 31 shares — an estimated $10K sold.

Foster Dykema Cabot & Co first reported a position in INSP in Q2 2023 and held it in 1 quarter. The position peaked at $10K in Q2 2023. 364 funds tracked by Wall St. Rank hold INSP as of Q3 2023.

  • Foster Dykema Cabot & Co reported no remaining Inspire Medical Systems position as of Q3 2023 after selling out during the quarter.
  • Foster Dykema Cabot & Co sold 31 Inspire Medical Systems shares in Q3 2023, an estimated $10K.
  • Foster Dykema Cabot & Co first reported a position in Inspire Medical Systems in Q2 2023 and held it in 1 quarter.
  • Foster Dykema Cabot & Co's Inspire Medical Systems position peaked at $10K in Q2 2023.
  • 364 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.